Humana says drugmakers can't avoid US antitrust claims over generic pricing
MLex Summary: Humana opposed motions for summary judgment filed by Novartis, Sandoz, and other generic drugmakers over the pricing of various drugs. “There is overwhelming evidence (both direct and circumstantial) in...To view the full article, register now.
Already a subscriber? Click here to view full article